Two geneticists explain the groundbreaking CRISPR-based therapies approved for sickle-cell disease and β-thalassaemia, and other genetic therapeutics in development, including base-editing and prime-editing.
The era of CRISPR therapeutics is here — what can we expect?
Posted in biotech/medical, genetics